• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apogee Therapeutics, Inc. - Common Stock (NQ:APGE)

134.50 +0.28 (+0.20%)
Streaming Delayed Price Updated: 11:23 AM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apogee Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
IPO watch 2024: Which new stocks will hit the market?
January 08, 2024
Expectations are high for the 2024 IPO market, with Reddit, Databricks, and Shein debuts anticipated, hinting at a substantial influx of new public companies. 
Via MarketBeat
Topics Initial Public Offering
News headline image
Apogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Apogee Highlights Corporate Progress and Reports Third Quarter 2023 Financial Results
November 13, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
December 22, 2023
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. 
Via Benzinga
News headline image
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
October 30, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
7 Biotech Stocks to Get In Now Before Investors Catch On ↗
October 23, 2023
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them. 
Via InvestorPlace
News headline image
Apogee Announces Two Abstracts Accepted for Presentation at the 2023 European Academy of Dermatology and Venereology (EADV) Congress
September 27, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Apogee Therapeutics to Participate at the 2023 Stifel Virtual I&I Day
September 14, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
August 28, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Apogee Therapeutics Appoints Mark C. McKenna, Healthcare Veteran and Former Chairman, President and CEO of Prometheus Biosciences, as Chairman of its Board
August 21, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗
August 08, 2023
 
Via Benzinga
News headline image
Apogee Announces First Participants Dosed Ahead of Schedule in Phase 1 Trial of APG777, its Novel Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
August 07, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Apogee Therapeutics to Participate in Upcoming August Investor Conferences
August 02, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Apogee Therapeutics, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 18, 2023
From Apogee Therapeutics, LLC
Via GlobeNewswire
News headline image
Apogee, Sagimet Debut This Week In First Big IPOs Of Summer ↗
July 16, 2023
Sagimet and Apogee both made their trading debuts this week, raising cash for their clinical trials after upsizing their respective IPOs. Inflammation and immunology biotech Apogee had the larger of... 
Via Talk Markets
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap